News Meta-analysis gives intravitreal ranibizumab vascular adverse risk profile by The Medical News • 2015/02/13 • 0 Comments Intravitreal ranibizumab treatment for age-related macular degeneration does not elevate the risk of mortality, suggests a meta-analysis published in Ophthalmology. Full Story →